selexipag (Uptravi)
Jump to navigation
Jump to search
Indications
Adverse effects
Mechanism of action
More general terms
References
- ↑ FDA News Release. December 22, 2015 FDA approves new orphan drug to treat pulmonary arterial hypertension. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm478599.htm
- ↑ Sitbon O, Channick R, Chin KM et al. Selexipag for the treatment of pulmonary arterial hypertension. N Engl J Med 2015 Dec 24; 373:2522 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/26699168 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMoa1503184